8/4/2025 9:40:31 AM Council adopts its position on EU pharmaceutical law reform: focus on antimicrobials and transferable data exclusivity vouchers By Caroline Arrighi-Savoie Nour Saab Margot Pietri This article is part of a series covering updates to the proposed European Union (EU) pharmaceutical legislation reform, known as the...
7/8/2025 8:00:47 AM EU Pharmaceutical Law Reform: Key Changes on Advertising of Medicinal Products By Kevin Munungu In 2023, the European Commission proposed a comprehensive update of the key EU pharmaceutical legislation (the "Pharma Package") to...
2/17/2025 8:30:15 AM A Sea Change for Pharma: EU's Urban Wastewater Treatment Directive and its Cost Implications By Marc Martens Kevin Munungu A new European directive is set to significantly impact pharmaceutical companies operating within the European Union. Directive (EU)...
1/29/2025 11:15:40 AM First decision on the SPC manufacturing waiver by the Belgian courts By Domien Op de Beeck Camille Vanpeteghem On 23 December 2024, the Brussels enterprise court issued a first decision in Belgium on the so-called “SPC manufacturing waiver”. Under...
10/9/2024 1:41:38 PM Case C-237/22 of the CJEU – Clarification of the concepts of “Significant Benefit” and “Clinical Superiority” By Marc Martens Benedicte Mourisse The CJEU brings clarity, on the concepts of “Significant Benefit” and “Clinical Superiority” with respect to Orphan Medicinal Products...